Olopatadine hydrochloride and Fever - a phase IV clinical study of FDA data
Summary:
We study 4,113 people who have side effects when taking Olopatadine hydrochloride. Fever is found, especially among people who are male, 60+ old, have been taking the drug for < 1 month, also take Xyzal and have Rashes.
The phase IV clinical study analyzes which people take Olopatadine hydrochloride and have Fever. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
4,113 people reported to have side effects when taking Olopatadine hydrochloride.
Among them, 157 people (3.82%) have Fever.
What is Olopatadine hydrochloride?
Olopatadine hydrochloride has active ingredients of olopatadine hydrochloride. Currently, eHealthMe is studying from 4,134 Olopatadine hydrochloride users.
What is Fever?
Fever is found to be associated with 4,938 drugs and 6,043 conditions by eHealthMe. Currently, we are studying 472,335 people who have Fever.
Number of Olopatadine hydrochloride and Fever reports submitted per year:
Time on Olopatadine hydrochloride when people have Fever *:
Gender of people who have Fever when taking Olopatadine hydrochloride*:
Age of people who have Fever when taking Olopatadine hydrochloride *:
Common drugs people take besides Olopatadine hydrochloride *:
Common side effects people have besides Fever *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Olopatadine hydrochloride and have Fever?
Check whether Fever is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Schiller D, Maieron A, Sch?fl R, Donnerer J, "Drug fever due to a single dose of pantoprazole", Pharmacology, 2015 Jan .
Related studies
Olopatadine hydrochloride side effects by duration, gender and age:
- Olopatadine hydrochloride side effects (4,134 reports)
Fever treatments and more:
- Fever (472,335 reports)
Common drugs associated with Fever:
- Prednisone: 26,713 reports
- Methotrexate: 20,661 reports
- Humira: 18,277 reports
- Enbrel: 13,289 reports
- Aspirin: 12,477 reports
- Omeprazole: 11,534 reports
- Tylenol: 11,340 reports
- Prednisolone: 10,764 reports
- Cyclophosphamide: 9,920 reports
- Pantoprazole: 9,677 reports
All the drugs that are associated with Fever:
- Fever (4,938 drugs)
Common conditions associated with Fever:
- Rheumatoid arthritis: 25,712 reports
- Multiple sclerosis: 17,600 reports
- High blood pressure: 14,574 reports
- Crohn's disease: 10,827 reports
- Multiple myeloma: 10,715 reports
- Pain: 10,593 reports
All the conditions that are associated with Fever:
- Fever (6,043 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on olopatadine hydrochloride (the active ingredients of Olopatadine hydrochloride) and Olopatadine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Isosorbide Dinitrate and Hepatitis Acute - 7 seconds ago
- Temovate and Oxycontin drug interaction - 10 seconds ago
- Mozobil and Hypotension - 11 seconds ago
- Probenecid and Alprazolam drug interaction - 12 seconds ago
- Micardis and Ultracet drug interaction - 13 seconds ago
- Neulasta and Joint Swelling - 15 seconds ago
- Omnipaque 140 and Carbamazepine drug interaction - 16 seconds ago
- Siliq and Pain - 17 seconds ago
- Propulsid and Pulmonary Embolism - 18 seconds ago
- Paracetamol and Skin Infection Aggravated - 27 seconds ago